Glenmark Pharmaceuticals gains as its US arm launches Lacosamide Oral Solution
Glenmark Pharmaceuticals is currently trading at Rs. 1531.70, up by 14.50 points or 0.96% from its previous closing of Rs. 1517.20 on the BSE. The scrip opened at Rs. 1510.80 and has touched a high and low of Rs. 1550.75 and Rs. 1501.50 respectively. So far 2765 shares were traded on the counter. The BSE … Read more